Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions.
Table of Contents
|2 A Lesson About Precompetitive Collaboration||9-12|
|3 Requisites for Successful Precompetitive Collaboration||13-20|
|4 Frameworks for Collaboration||21-30|
|5 The Use of Biospecimens in Precompetitive Collaborations||31-44|
|6 Ethical Challenges in the Use of Biospecimens||45-48|
|7 Toward Developing a Cultural, Legal, and Behavioral Framework for Precompetitive Collaboration||49-54|
|Appendix A: Workshop Agenda||57-62|
|Appendix B: Speaker Biographical Sketches||63-74|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development: Workshop Summary...